Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-operative antibiotics after laparoscopic appendectomy for complicated acute appendicitis
2024-515834-34-00Phase 3Authorised
- Sponsor
- CHU Amiens-Picardie
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ceftriaxone, metronidazole and levofloxacin in acute appendicitis (2 arms), sponsored by CHU Amiens-Picardie. Primary endpoint: Deep surgical site infection by postoperative day 30. Planned start Nov 2024; status: authorised.
02
Drugs
ceftriaxonemetronidazolelevofloxacin
03
Conditions
acute appendicitis
Beyond the preview
Go deeper on 2024-515834-34-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-515834-34-00.